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The numbers of older adults are growing rapidly globally
with the rate of increase larger in less developed countries.
As life expectancies increase around the world, it is a
priority to determine if more of the extra years being
added are healthy years or years that are likely to be spent
in poor health.
The Study on Global Ageing and Adult Health (SAGE)
of the World Health Organisation (WHO) (http://www.
who.int/healthinfo/sage) is a longitudinal nationally
representative household survey that includes respon-
dents 50 years and older with a smaller, comparative
cohort of adults aged 18-49 years in China, Ghana, India,
Mexico, Russia and South Africa with a sample size of
over 40,000 respondents selected using a multi-stage
cluster design. Additionally, eight health and demo-
graphic surveillance sites (HDSS) in Bangladesh, Ghana,
India, Indonesia, Kenya, South Africa, Tanzania and Viet
Nam with an additional combined sample size of over
45,000 respondents are a part of SAGE. The Collabora-
tive Research on Ageing in Europe (COURAGE) project
has also used SAGE methods and instruments to collect
data in Finland, Poland and Spain.
The objective of SAGE is to improve the empirical
understanding of the health and well-being of older adults
through provision of reliable, valid and cross-nationally
comparable data over time on key outcomes and determi-
nants. Wave 0 was completed in 2004 with Wave 1 fina-
lised in 2010. Wave 2 of SAGE is planned for later in 2013
and Wave 3 in 2015. The biomarker component of SAGE
includes performance tests and the collection of dried
blood spots in Wave 1. Dried Blood Spot (DBS) samples
have been collected from approximately 40,000 respon-
dents and stored. The assays for haemoglobin, glycosylated
haemoglobin (HbA1c), high sensitivity C-reactive protein
(hsCRP), Epstein Barr Virus (EBV) and HIV are being car-
ried out initially with additional assays planned for the
future. Future waves of SAGE will consider the collection
of DNA samples.
First results from SAGE reveal significant declines in
health over the life span with female and poorer respon-
dents being in worse health at all ages. Chronic health con-
ditions are extremely prevalent. Risk factors such as
tobacco use, inadequate physical activity, obesity and
hypertension are all very common. Poor health is asso-
ciated with declining subjective well-being and shrinking
social networks.
This suggests that there is little evidence of healthy age-
ing in these populations and that a concerted response
will be required from health systems to address the needs
of this rapidly growing segment of the population.
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